


Subcutaneous NAD+ skips first-pass metabolism and raises whole-blood NAD+ within hours. Cycled under clinical review, with labs bracketing every course. No immortality pitch.
NAD+ is a rate-limiting coenzyme in mitochondrial metabolism, DNA repair (PARP), and sirtuin signaling. SubQ delivery bypasses first-pass metabolism and raises whole-blood NAD+ within hours; oral NR/NMN raises metabolites more slowly. Human outcome data is early - ALUKARD positions NAD+ as a provider-supervised layer on top of a clean metabolic baseline, not as a standalone longevity lever.
Complete assessment. A licensed provider determines eligibility and appropriate care steps.
Subscribe & Save
Cancel anytime
$249/mo
One-time
After provider review
$249
Related reading
Injectable NAD+ vs oral precursors: picking a format that actually raises NAD
NAD+ gets sold at $400 IV clinics, as $70 subQ injection kits, and as $80 oral NR or NMN bottles. Only two of those options have human data worth quoting. IV...
ReadNAD and longevity markers: what we know, what's hype
NAD+ IV drips sell at $400-800 a session. NMN bottles have become the supplement aisle's hottest trend. Meanwhile, the labs with the strongest longevity...
ReadLongevity
ApoB, hs-CRP, HbA1c, fasting insulin, thyroid. Re-measured every quarter. Sequenced by a provider. Never sold as a stack.
ReadMetformin for longevity: what we know and what remains uncertain
Metformin is often framed as a longevity shortcut, but evidence strength differs by population and endpoint. It has a clear role in glycemic management and...
ReadNAD
A coenzyme that powers mitochondria and DNA repair - drops ~50% between age 30 and 70.
ReadOral vs injectable semaglutide: convenience against efficacy and adherence
Oral semaglutide offers needle-free convenience, but injectable formulations still dominate weight-loss efficacy and dosing flexibility. This guide compares...
Read